BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 23786229)

  • 1. Benefits of short-term professional continuous glucose monitoring in clinical practice.
    Leinung M; Nardacci E; Patel N; Bettadahalli S; Paika K; Thompson S
    Diabetes Technol Ther; 2013 Sep; 15(9):744-7. PubMed ID: 23786229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
    Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
    Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
    Ehrhardt NM; Chellappa M; Walker MS; Fonda SJ; Vigersky RA
    J Diabetes Sci Technol; 2011 May; 5(3):668-75. PubMed ID: 21722581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
    Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
    Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
    Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.
    Tildesley HD; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; Tang TS; White AS
    Can J Diabetes; 2013 Oct; 37(5):305-8. PubMed ID: 24500556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
    Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBA1C AND MEAN GLUCOSE DERIVED FROM SHORT-TERM CONTINUOUS GLUCOSE MONITORING ASSESSMENT DO NOT CORRELATE IN PATIENTS WITH HBA1C >8.
    Yamada E; Okada S; Nakajima Y; Bastie CC; Vatish M; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Okamura T; Ozawa A; Yamada M
    Endocr Pract; 2017 Jan; 23(1):10-16. PubMed ID: 27631849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice.
    Anderson J; Attvall S; Sternemalm L; Pivodic A; Fahlén M; Hanås R; Ekeroth G; Lind M
    J Diabetes Sci Technol; 2011 Nov; 5(6):1472-9. PubMed ID: 22226268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.